Clinical Trials on Blood-Borne Infections

Total 148520 results

Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir/Ledipasvir ± Ribavirin in Japanese Participants With Chronic Genotype 1 HCV Infection

Chronic HCV Infection

Japan
Gilead Sciences

Completed

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment (Co-STARs)

HIV-1 Infection | HCV Infection

United States, Puerto Rico
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Sint...

Completed

Persistent Lyme Empiric Antibiotic Study Europe (PLEASE)

Lyme Disease | Borrelia Infection

Netherlands
Noguchi Memorial Institute for Medical Research
Ghana Health Services

Completed

Twice Yearly Treatment for the Control of LF

Lymphatic Filariasis | Helminth Infection

Ghana
ANRS, Emerging Infectious Diseases

Recruiting

Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia (HEPEDIAC)

HCV Infection

Cambodia
Nanjing Sanhome Pharmaceutical, Co., Ltd.

Completed

Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection

HCV Infection

China
Erasmus Medical Center
Public Health Service of Rotterdam-Rijnmond

Recruiting

Prevalence of HCV in HIV-negative MSM

Hepatitis C Virus Infection

Netherlands
ReiThera Srl
University of Oxford; Oxford University Hospitals NHS Trust; University Hospital...

Completed

Study of a New MVA Vaccine for Hepatitis C Virus

Hepatitis C Infection

United Kingdom
Institut de Recherche pour le Developpement
Ministry of Health, Thailand

Completed

HCV-HIV Co-infected Patient Cohort in Thailand

HIV | Hepatitis C Infection

Thailand
Huashan Hospital

Recruiting

Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT) (STAT)

Hepatitis C Virus Infection

China
Assiut University

Unknown

the Possible Effect of the Antiviral Inhibitors for Treatment of Hepatitis C Virus Infection in Cardiac Function

Hepatitis

Egypt
Syneos Health
F-star Therapeutics, Inc.

Completed

A Multiple Ascending Dose Phase I Study of SB 9200 in Treatment Naïve Adults With Chronic Hepatitis C Infection

Hepatitis C Infection

Australia, New Zealand
University Children's Hospital, Zurich
Institute of Medical Microbiology, University of Zurich, Zurich, Switzerland

Recruiting

Borrelia B-cell Diagnostics (BRILLIANT)

Lyme Disease | Borrelia Infections

Switzerland
University of Oxford
GlaxoSmithKline; ReiThera Srl

Completed

A Study to Assess the Safety of HIV and Hep C Vaccine Candidates When Given Separately or in Combination

HIV Infection | Hepatitis C Infection

United Kingdom
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection

Chronic HCV Infection

China, Hong Kong, Taiwan, Korea, Republic of, Vietnam
University Children's Hospital Basel

Recruiting

BOrrelia BUrgdorferi IN Children and Adolescents (BOBUINCA)

B. Burgdorferi Infection

Switzerland
Prof. Dr. Ulrich Heininger
Luzerner Kantonsspital

Completed

Long- and Midterm Outcomes of Osteoarticular Infections in Paediatric Patients (LOOP)

Septic Arthritis | Acute Haematogenous Osteomyelitis

Switzerland
Ginkgopharma CO., LTD

Unknown

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients

Hepatitis C Virus Infection

China
Gilead Sciences

Completed

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Chronic HCV Infection

Belgium, Austria, New Zealand, United Kingdom, Germany, Spain, Netherlands, France, Switzerland, Canada, Australia, Italy
Vertex Pharmaceuticals Incorporated
Duke Clinical Research Institute; ViroChem Pharma

Completed

Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection

HCV Infection

Puerto Rico, United States, Canada
University of Maryland, Baltimore
Merck Sharp & Dohme LLC; Maryland Department of Public Safety and Correctional...

Withdrawn

Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE) (ECLIPSE)

HCV Infection

United States
Gilead Sciences

Completed

Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

HCV Infection

New Zealand
AbbVie (prior sponsor, Abbott)

Completed

A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 Studies

HCV Infection

United States, Puerto Rico
Hannover Medical School
European Union; German Center for Infection Research; German Liver Foundation...

Recruiting

A Non-interventional Registry for Patients With Hepatitis B Virus Infection

Hepatitis B Virus Infection

Germany
Gilead Sciences

Completed

Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant

Hepatitis C Virus Infection

Spain, Switzerland, United Kingdom
Gilead Sciences

Completed

Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant

Chronic HCV Infection

United States
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-Dose Combination ± Ribavirin in Cirrhotic Subjects With Chronic Genotype 1 HCV Infection

HCV Infection

France
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH)

Completed

Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection

Hepatitis C | HIV | Co-Infection

United States
Hoffmann-La Roche

Completed

Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

HCV Infection

United States, Puerto Rico
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects

Zika Virus

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

Zika Virus

United States, Puerto Rico
AbbVie

Completed

Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects

HCV Infection
AbbVie

Completed

Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1

HCV Infection

United States
Abbott

Completed

Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

HCV Infection

United States
Abbott

Completed

A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Doses of ABT-072 Used to Treat Hepatitis C

HCV Infection

United States
Abbott

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of the ABT-333 Tablet

HCV Infection

United States
Abbott

Completed

Bioavailability of ABT-333 Tablet Versus First in Human (FIH) Capsule Formulation and Safety, Tolerability and PK Study of Single Doses of ABT-333 in Healthy Volunteers

HCV Infection

United States
National Institute of Allergy and Infectious Diseases...
University of Maryland, Baltimore; Makerere University

Recruiting

Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria

Plasmodium Falciparum Infection

Uganda
National Institute of Allergy and Infectious Diseases...
National Institutes of Health (NIH); University of Washington; Harvard School... and other collaborators

Active, not recruiting

Anti-malaria MAb in Malian Children (L9LS)

Malaria | Plasmodium Falciparum Infection

Mali
Uskudar State Hospital

Not yet recruiting

Awareness of Osteoporosis in Patients With Hepatitis B Infection

Hepatitis B | Osteoporosis | Osteoporosis Risk
National Institute of Allergy and Infectious Diseases...

Completed

Malaria Incidence in Infants in Bancoumana, Mali

Anemia | Malaria Infection | Malaria Incidence

United States
Bangabandhu Sheikh Mujib Medical University, Dhaka...

Unknown

Risk of Tuberculous and Other Infections in Patients of Spondyloarthritis Treated With Tofacitinib in Bangladesh

Spondyloarthritis

Bangladesh
Abbott
Abbott Japan Co.,Ltd

Completed

A Study of Single Dose of ABT-333 in Healthy Male Adults

HCV Infections

Japan
National Institute of Allergy and Infectious Diseases...
National Institutes of Health (NIH); Centers for Disease Control and Prevention and other collaborators

Recruiting

Anti-malaria MAb in Kenyan Children

Malaria | Plasmodium Falciparum Infection

Kenya
DBL -Institute for Health Research and Development
Danish Council for Development Research; The AIDS Foundation, Denmark; The Wedell-Wedellsborg...

Completed

Interaction Between HIV and Lymphatic Filariasis

HIV Infection | Lymphatic Filariasis
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis

Hepatitis C Virus Infection

Japan
Hospices Civils de Lyon

Completed

HBV Virions Bound Proteins

Hepatitis B Virus Infection

France
Icahn School of Medicine at Mount Sinai
Centers for Disease Control and Prevention; National Institute for Occupational...

Completed

Hepatitis C Infection in World Trade Center Responders

Hepatitis C Infection

United States
HepNet Study House, German Liverfoundation
Gilead Sciences; Hannover Medical School

Completed

HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection

Acute Hepatitis C

Germany
Ginkgopharma CO., LTD

Unknown

Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients

Hepatitis C Virus Infection

China

Clinical Trials on Blood-Borne Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations